determin
whether
frontlin
health
care
worker
hcw
greater
risk
contract
pandem
nonclin
staff
conduct
studi
hcw
control
overal
posit
antibodi
titer
hemagglutin
inhibit
hcw
control
posit
confi
denc
interv
particip
provid
second
serum
sampl
show
rise
antibodi
titer
patient
nose
swab
sampl
taken
respiratori
ill
posit
result
higher
number
children
particip
famili
work
intens
care
unit
risk
factor
infect
increas
age
work
hospit
wear
glove
protect
factor
highli
expos
group
frontlin
hcw
like
contract
pandem
infl
uenza
infect
nonclin
staff
suggest
person
protect
measur
adequ
prevent
transmiss
ustralia
affect
earli
infl
uenza
pandem
case
death
report
state
victoria
fi
rst
observ
substanti
peak
number
person
infect
pandem
manag
within
framework
australian
health
manag
plan
pandem
infl
uenza
guidelin
use
person
protect
equip
ppe
establish
victorian
health
manag
plan
pandem
infl
uenza
recommend
includ
use
mask
glove
protect
eyewear
longsleev
gown
infl
uenza
health
care
worker
hcw
common
acquisit
workplac
well
document
uncontrol
studi
found
infl
uenza
epidem
glasgow
scotland
hcw
seroconvert
earli
twelv
hcw
probabl
possibl
work
place
acquisit
pandem
infl
uenza
report
unit
state
none
worn
full
ppe
hcw
may
concern
attend
work
potenti
seriou
infl
uenza
pandem
surpris
sever
acut
respiratori
syndrom
outbreak
hcw
reportedli
stay
home
fear
becom
infect
transmit
infect
famili
member
number
survey
found
hcw
may
report
work
event
infl
uenza
pandem
hcw
need
know
transmiss
risk
make
ration
decis
work
infl
uenza
pandem
hcw
expos
commun
well
workplac
know
addit
risk
contract
infl
uenza
work
inform
also
imper
pandem
workforc
plan
sought
determin
whether
frontlin
hcw
greater
risk
contract
pandem
infl
uenza
control
group
addit
sought
inform
factor
may
increas
decreas
risk
infect
conduct
cohort
studi
compar
frontlin
hcw
intens
patient
contact
clinic
staff
patient
contact
nonclin
frontlin
hcw
defi
ned
work
shift
per
week
like
exposur
patient
pandem
infl
uenza
infect
worker
includ
doctor
nurs
physiotherapist
well
other
emerg
depart
intens
care
unit
infecti
diseas
unit
respiratori
ward
patient
suspect
pandem
infl
uenza
hous
staff
member
clinic
contact
chosen
conveni
surrog
commun
control
group
worker
includ
univers
hospit
staff
nonpati
contact
area
librari
inform
technolog
administr
studi
approv
human
research
ethic
committe
hospit
particip
gave
written
inform
consent
studi
conduct
august
decemb
four
tertiari
referr
hospit
metropolitan
melbourn
involv
royal
melbourn
st
vincent
austin
alfr
hospit
site
patient
suspect
confi
rmed
pandem
infl
uenza
infect
care
neg
pressur
isol
room
avail
privat
room
institut
infect
control
polici
direct
glove
gown
goggl
mask
use
care
patient
use
mask
initi
recommend
hospit
although
hospit
chang
surgic
mask
june
hand
hygien
alcoholbas
product
respiratori
etiquett
promot
hospit
progress
pandem
victoria
shown
figur
origin
research
plan
obtain
serum
sampl
month
apart
particip
test
seroconvers
also
obtain
weekli
nose
swab
pandem
infl
uenza
detect
use
realtim
pcr
time
studi
commenc
pandem
wane
infl
uenza
case
decreas
victoria
follow
origin
studi
plan
consid
feasibl
plan
thu
modifi
ed
initi
serum
sampl
obtain
particip
measur
pandem
infl
uenza
antibodi
studi
entri
particip
complet
webor
paperbas
questionnair
request
inform
demograph
characterist
known
infl
uenza
exposur
outsid
workplac
histori
fever
respiratori
symptom
occur
pandem
studi
addit
clinic
group
ask
work
exposur
patient
suspect
pandem
infl
uenza
usual
use
ppe
care
patient
particip
also
ask
use
neuraminidas
inhibitor
ni
specifi
calli
whether
receiv
prophylaxi
exposur
patient
confi
rmed
infl
uenza
particip
instruct
provid
nose
swab
specimen
viral
test
experienc
sign
symptom
includ
cough
sore
throat
rhinorrhea
laryng
fever
myalgia
headach
ask
complet
weekli
questionnair
regard
symptom
infl
uenza
exposur
use
ni
particip
report
respiratori
ill
second
serum
sampl
request
antibodi
test
document
possibl
seroconvers
serum
test
antibodi
pandem
infl
uenza
viru
use
hemagglutin
inhibit
assay
viru
turkey
red
blood
cell
titer
defi
ned
neg
posit
nucleic
acid
detect
perform
nasal
swab
use
revers
transcript
pcr
rtpcr
infl
uenzaspecifi
c
pandem
virusspecifi
c
sequenc
swab
kit
provid
center
diseas
control
prevent
atlanta
ga
usa
instrument
world
health
organ
collabor
centr
refer
research
infl
uenza
melbourn
basi
earli
estim
antibodi
posit
pandem
infl
uenza
viru
commun
assum
infect
rate
clinic
staff
rate
nonclin
staff
calcul
particip
requir
achiev
power
detect
differ
use
twotail
signifi
canc
level
primari
outcom
presenc
posit
antibodi
titer
fi
rst
serum
sampl
indic
like
pandem
infl
uenza
infect
perform
separ
univari
multivari
analys
delin
put
risk
protect
factor
includ
particip
includ
clinic
particip
investig
associ
health
carespecifi
c
risk
factor
pandem
infl
uenza
multivari
analysi
perform
use
forward
backward
stepwis
logist
regress
includ
variabl
model
initi
p
valu
remov
studi
took
place
august
decemb
larg
releas
pandem
infl
uenza
vaccin
particip
vaccin
studi
tabl
show
number
patient
confi
rmed
pandem
infl
uenza
infect
pcr
treat
hospit
characterist
studi
particip
shown
tabl
median
particip
age
year
rang
year
year
age
year
age
year
age
year
age
figur
show
revers
cumul
distribut
fi
rst
serum
antibodi
titer
accord
age
found
statist
signifi
cant
differ
curv
p
ordin
logist
regress
multivari
logist
regress
factor
associ
higher
risk
pandem
infl
uenza
among
particip
younger
age
ci
adjust
particip
statu
clinic
vs
nonclin
age
gender
hospit
season
infl
uenza
vaccin
confi
rmed
pandem
infl
uenza
report
respiratori
ill
commun
contact
infl
uenza
oseltamivir
prophylaxi
number
children
household
year
age
hour
work
per
week
univari
analysi
factor
signifi
cantli
associ
protect
infect
clinic
group
use
mask
ci
use
glove
ci
patient
droplet
precaut
adjust
odd
ratio
shown
tabl
particip
report
respiratori
ill
nose
swab
taken
seven
posit
pandem
viru
pcr
subtyp
infl
uenza
neg
one
swab
taken
differ
ill
fi
rst
posit
second
neg
pandem
viru
pcr
cycl
threshold
valu
swab
specimen
indic
low
viral
load
fi
nding
may
indic
poor
swab
techniqu
use
sampl
taken
infect
wane
level
infect
low
data
shown
particip
second
serum
sampl
taken
report
respiratori
ill
averag
number
day
fi
rst
second
sampl
day
rang
day
median
day
thirtysix
particip
nose
swab
perform
also
second
serum
sampl
taken
seroconvers
occur
worker
initi
titer
subsequ
titer
day
later
particip
nose
swab
taken
respiratori
infect
neg
infl
uenza
viru
seroconvers
occur
particip
posit
nose
swab
specimen
mean
number
day
obtain
one
particip
posit
nose
swab
sampl
second
serum
sampl
taken
none
particip
posit
nose
swab
seroconvers
report
take
ni
weekli
survey
four
particip
posit
pcr
result
seroconvers
occur
clinic
group
doctor
pharmacist
nurs
physiotherapist
particip
show
seroconvers
year
age
particip
posit
pcr
result
rang
year
age
two
particip
posit
pcr
result
work
infecti
diseas
ward
emerg
depart
intens
care
unit
seroconvers
occur
particip
work
medic
ward
five
particip
posit
pcr
result
particip
seroconvers
occur
receiv
previou
season
infl
uenza
vaccin
none
particip
confi
rmed
infl
uenza
report
take
oseltamivir
either
prophylaxi
treatment
total
particip
complet
weekli
questionnair
eightynin
clinic
nonclin
particip
report
respiratori
ill
respect
particip
report
laboratoryconfi
rmed
pandem
infl
uenza
six
report
commun
contact
someon
laboratoryconfi
rmed
infect
one
report
take
oseltamivir
contact
infect
person
workplac
person
serum
sampl
taken
day
apart
antibodi
titer
studi
evalu
risk
pandem
hcw
compar
risk
infect
control
group
well
factor
associ
infect
hcw
slightli
higher
rate
seroposit
nonclin
staff
howev
differ
statist
signifi
cant
data
support
result
anoth
recent
studi
found
hcw
risk
factor
serolog
confi
rmed
season
infl
uenza
viru
infect
risk
hcw
acquir
infl
uenza
strongli
associ
household
workplac
exposur
studi
found
seroconvers
rate
hcw
nonhcw
howev
examin
doctor
nurs
wherea
studi
includ
type
frontlin
hcw
anoth
studi
report
seropreval
pandem
hcw
signifi
cantli
differ
seropreval
gener
popul
neither
studi
examin
use
ppe
overal
found
particip
serolog
evid
pandem
viru
infect
peak
outbreak
proport
refl
ect
observ
seropreval
adult
melbourn
rate
lower
howev
antibodi
posit
found
south
australia
prelicensur
studi
pandem
infl
uenza
vaccin
juli
exclud
subject
confi
rmed
suspect
pandem
infl
uenza
differ
titer
may
refl
ect
geograph
differ
infect
rate
differ
popul
sampl
analysi
particip
found
older
age
associ
lower
rate
pandem
infl
uenza
infect
observ
higher
level
preexist
antibodi
pandem
infl
uenza
increas
age
previous
report
howev
result
studi
examin
relationship
seropreval
increas
age
confl
ict
immun
mechan
typespecifi
c
antibodi
may
provid
protect
older
particip
possibl
older
person
older
children
may
less
like
acquir
transmit
infl
uenza
older
particip
conscienti
respiratori
etiquett
hand
hygien
attempt
measur
factor
includ
studi
among
hcw
studi
work
hospit
confer
protect
pandem
viru
infect
hospit
geograph
area
fewer
case
other
explan
similar
fi
nding
might
expect
nonclin
group
demonstr
furthermor
least
mani
case
confi
rmed
pandem
infl
uenza
seen
hospit
seen
hospit
tabl
factor
report
complianc
ppe
adjust
multivari
analysi
reduc
effect
hospit
type
infl
uenza
risk
reason
lower
risk
associ
hospit
identifi
ed
may
relat
unmeasur
factor
complianc
hand
hygien
procedur
wear
glove
care
patient
part
droplet
precaut
strongli
associ
lower
risk
pandem
viru
infect
use
glove
highli
correl
use
gown
mask
eye
protect
logist
regress
result
shown
fi
nding
confi
rm
great
import
ppe
prevent
transmiss
respiratori
virus
health
care
set
may
explain
hcw
defi
nite
exposur
infl
uenza
workplac
addit
probabl
exposur
commun
higher
rate
infect
commun
exposur
risk
pandem
viru
infect
increas
number
children
year
age
live
particip
household
previous
report
risk
factor
victoria
median
age
person
report
pandem
viru
infect
year
notifi
ed
casepati
year
age
miller
et
al
also
found
children
predominantli
infect
fi
nding
coupl
diffi
culti
maintain
good
respiratori
etiquett
young
children
plausibl
explan
effect
child
number
infect
risk
work
icu
also
identifi
ed
risk
factor
pandem
infl
uenza
patient
icu
may
sever
ill
high
viral
load
staff
may
heavili
expos
multipl
aerosolgener
procedur
addit
use
ppe
hand
hygien
complianc
may
lower
ward
patient
pandem
infl
uenza
may
unrecogn
therefor
appropri
ppe
use
exposur
hcw
suspect
proven
pandem
infl
uenza
commun
protect
posit
antibodi
test
result
fi
nding
counterintuit
diffi
cult
explain
one
hypothesi
hcw
knew
commun
exposur
may
attent
hand
hygien
infect
control
precaut
work
like
enact
social
distanc
found
instanc
seroconvers
among
particip
includ
pcrconfi
rmed
infect
serum
sampl
taken
antibodi
measur
miller
et
al
report
particip
pandem
antibodi
titer
three
week
infect
although
baselin
serum
sampl
taken
therefor
seroconvers
could
demonstr
none
particip
posit
pcr
result
report
take
ni
serum
sampl
taken
week
posit
nose
swab
specimen
allow
suffi
cient
time
seroconvers
result
like
true
posit
swab
taken
patient
symptomat
previous
viru
isol
gold
standard
infl
uenza
detect
rtpcr
consid
sensit
specifi
c
previou
studi
current
author
shown
seroconvers
occur
serum
sampl
test
suffi
cient
time
infect
confi
rmed
rtpcr
nasal
swab
rel
peripher
type
sampl
viral
load
low
nose
sampl
may
insuffi
cient
antigen
stimulu
induc
detect
level
seroconvers
serum
may
explan
lack
seroconvers
seen
pcrposit
case
studi
number
pandem
case
victoria
low
time
studi
commenc
use
singl
antibodi
measur
diagnosi
patient
ideal
particip
may
preexist
crossreact
antibodi
report
other
howev
crossreact
commonli
found
older
person
year
age
popul
underrepres
studi
explan
given
presenc
crossreact
antibodi
older
person
past
exposur
antigen
similar
virus
lifetim
exposur
infl
uenza
viru
exposur
could
occur
younger
studi
particip
median
age
year
serum
sampl
collect
toward
end
pandem
wave
mani
would
alreadi
expos
reactiv
like
specifi
c
pandem
factor
support
use
singl
antibodi
measur
diagnosi
studi
reli
selfreport
symptom
risk
factor
includ
use
ppe
make
subject
recal
bia
particular
problem
potenti
recal
exposur
eg
other
infl
uenza
use
ppe
howev
mani
predictor
variabl
subject
recal
bia
eg
clinic
nonclin
statu
work
place
age
gender
occup
number
children
household
addit
order
infl
uenc
result
exposur
group
would
exhibit
differenti
recal
although
could
postul
hcw
may
perceiv
greater
risk
exposur
may
therefor
conscienti
fi
lling
questionnair
believ
larg
amount
public
awar
pandem
time
unlik
group
would
conscienti
nonclin
group
conclus
found
hcw
substanti
increas
risk
contract
pandem
health
care
set
high
avail
ppe
conclud
use
ppe
highli
protect
acquir
pandem
viru
infect
therefor
encourag
use
along
scrupul
hand
hygien
respiratori
etiquett
